Journal article · 2022 · Open access

Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics

Elodie Bosc, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, Kaitao Zhao, Ronak Patel, Eric Duplus, Philippe Tixador, Andrew A. Sproul and 8 more

Cell Death and Disease, 13(11), 959 · Published 15 November 2022 · DOI 10.1038/s41419-022-05396-2

Open PDFView at the publisherCite this paper

In brief

“Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics” is a 2022 journal article by Elodie Bosc and 19 co-authors, published in Cell Death and Disease. OpenAlex counts 17 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cell Death and Disease.

Citations
17
Most cited in
2026 (7)
Field-weighted impact
0.66
References
50
Authors
20

Abstract

Caspase-2 (Casp2) is a promising therapeutic target in several human diseases, including nonalcoholic steatohepatitis (NASH) and Alzheimer’s disease (AD). However, the design of an active-site-directed inhibitor selective to individual caspase family members is challenging because caspases have extremely similar active sites. Here we present new peptidomimetics derived from the VDVAD pentapeptide structure, harboring non-natural modifications at the P2 position and an irreversible warhead. Enzyme kinetics show that these new compounds, such as LJ2 or its specific isomers LJ2a, and LJ3a, strongly and irreversibly inhibit Casp2 with genuine selectivity. In agreement with the established role of Casp2 in cellular stress responses, LJ2 inhibits cell death induced by microtubule destabilization or hydroxamic acid-based deacetylase inhibition. The most potent peptidomimetic, LJ2a, inhibits human Casp2 with a remarkably high inactivation rate ( k 3 / K i ~5,500,000 M −1 s − 1 ), and the most selective inhibitor, LJ3a, has close to a 1000 times higher inactivation rate on Casp2 as compared to Casp3. Structural analysis of LJ3a shows that the spatial configuration of C α at the P2 position determines inhibitor efficacy. In transfected human cell lines overexpressing site-1 protease (S1P), sterol regulatory element-binding protein 2 (SREBP2) and Casp2, LJ2a and LJ3a fully inhibit Casp2-mediated S1P cleavage and thus SREBP2 activation, suggesting a potential to prevent NASH development. Furthermore, in primary hippocampal neurons treated with β-amyloid oligomers, submicromolar concentrations of LJ2a and of LJ3a prevent synapse loss, indicating a potential for further investigations in AD treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., Tixador, P., Sproul, A. A., Brugg, B., Reboud-Ravaux, M., Troy, C. M., Shelanski, M. L., Bouaziz, S., Karin, M., El Amri, C., & Jacotot, E. D. (2022). Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics. Cell Death and Disease, 13(11), 959. https://doi.org/10.1038/s41419-022-05396-2

MLA 9

Bosc, Elodie, et al. “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.” Cell Death and Disease, vol. 13, no. 11, 2022, p. 959. https://doi.org/10.1038/s41419-022-05396-2.

Chicago

Bosc, Elodie, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, et al. 2022. “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.” Cell Death and Disease 13 (11): 959. https://doi.org/10.1038/s41419-022-05396-2.

Harvard

Bosc, E. et al. (2022) ‘Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics’, Cell Death and Disease, 13(11), p. 959. doi:10.1038/s41419-022-05396-2.

IEEE

E. Bosc et al., “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics,” Cell Death and Disease, vol. 13, no. 11, p. 959, 2022, doi: 10.1038/s41419-022-05396-2.

BibTeX

@article{bosc2022genuine,
  title     = {{Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics}},
  author    = {Bosc, Elodie and Anastasie, Julie and Soualmia, Feryel and Coric, Pascale and Kim, Ju Youn and Wang, Lily Q. and Lacin, Gullen and Zhao, Kaitao and Patel, Ronak and Duplus, Eric and Tixador, Philippe and Sproul, Andrew A. and Brugg, Bernard and Reboud-Ravaux, Michelle and Troy, Carol M. and Shelanski, Michael L. and Bouaziz, Serge and Karin, Michael and El Amri, Chahrazade and Jacotot, Etienne D.},
  journal   = {Cell Death and Disease},
  year      = {2022},
  volume    = {13},
  number    = {11},
  pages     = {959},
  doi       = {10.1038/s41419-022-05396-2},
  url       = {https://doi.org/10.1038/s41419-022-05396-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202444
202555
202677

Its field-weighted citation impact is 0.66: it has been cited 0.66 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation

  • caspase-2
  • site-1 protease
  • nonalcoholic steatohepatitis
  • Alzheimer's disease
  • amyloid-beta oligomers
  • hippocampal neurons
  • synaptic loss
  • microtubule destabilization

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., Tixador, P., Sproul, A. A., Brugg, B., Reboud-Ravaux, M., Troy, C. M., Shelanski, M. L., Bouaziz, S., Karin, M., El Amri, C., & Jacotot, E. D. (2022). Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics. Cell Death and Disease, 13(11), 959. https://doi.org/10.1038/s41419-022-05396-2

How many times has this paper been cited?

17 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell Death and Disease: sign in and open the PDF from this page.

Who wrote this paper?

Elodie Bosc, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, Kaitao Zhao, Ronak Patel, Eric Duplus, Philippe Tixador, Andrew A. Sproul and 8 more.

What is the DOI of this paper?

10.1038/s41419-022-05396-2, permanently at https://doi.org/10.1038/s41419-022-05396-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.